Q1 Stability Testing of Drug Substances and Drug Products; International Council for Harmonisation; Draft Guidance for Industry; Availability | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2025-D-1106

Q1 Stability Testing of Drug Substances and Drug Products; International Council for Harmonisation; Draft Guidance for Industry; Availability

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJun 24, 2025

Comment Period ClosesAug 26, 2025

Documents

Type	Title	Posted	Comments	Status
Notice	Q1 Stability Testing of Drug Substances and Drug Products; International Council for Harmonisation; Draft Guidance for Industry; Availability FR Doc: 2025-11552	Jun 24, 2025	--

Comment Statistics

Total Comments

Keywords

CDER

CBER

Guidance for Industry

Q1 Stability Testing of Drug

Substances and Drug Products

International Council for Harmonisation

OPEN

Data from Regulations.gov